Abstract The antimicrobial resistance and serotype distribution of Streptococcus pneumoniae (SP) among children attending day-care centres in south-eastern France were monitored from 1999 to 2008, before and after interventions promoting prudent antibiotic use initiated in 2000 and the availability of pneumococcal conjugate vaccine in 2003. Antibiotic susceptibility and serotypes of SP isolates were determined on nasopharyngeal samples of children aged 3-40 months attending day-care centres, from January to March 1999March , 2002March , 2004March , 2006March and 2008. SP carriage fell from 54% to 45%, and SP with diminished susceptibility to penicillin (PDSP) fell from 34% to 19%. Antibiotic prescriptions dropped from 63% to 38% of children, but third-generation cephalosporins were increasingly prescribed. The overall antibiotic susceptibility increased. Over 90% of the children had received at least one vaccine dose in 2008. Vaccine serotypes 6B, 9V, 19F and 23F (76%) in 1999 were replaced by non-vaccine types (95%) in 2008, among which were 15 (20%), 19A (15%), 23A/B (10%) and 6A (9%). Serotypes 6A, 19A and 15 accounted for over 50% of PDSP strains in 2008 versus 6% in 1999. Children now mostly harbour nonvaccine types; however, PDSP isolates are mainly recruited among these. Vaccine-related benefits may be threatened by combined vaccine-and antibiotic-driven selective pressure.
Introduction
Since the 7-valent pneumococcal conjugate vaccine (PCV7) became available, several studies in France and abroad have reported shifts in pneumococcal distribution as observed in blood or cerebrospinal fluid samples in the context of invasive disease or in nasopharyngeal samples in that of acute otitis media [1, 2] . Healthy day-care centre (DCC) attendees are known to be the major reservoirs and disseminators of pneumococci, so that carriage surveillance in this particular setting provides a reasonably accurate estimate of the distribution of pneumococcal strains circulating within the community [3, 4] . Frequent nasopharyngeal carriage of penicillin-non-susceptible Streptococcus pneumoniae (PDSP) and exposure to numerous antibiotic treatment courses were observed in the late 1990s among children attending DCCs in the Alpes Maritimes (AM), in south-eastern France [5] . In an effort to curb one of the highest rates of pneumococcal resistance and antibiotic use in Europe [6] , an intervention promoting prudent antibiotic use in the context of paediatric respiratory tract infections was implemented in AM in 2000, based on academic detailing visits to all local general practitioners and paediatricians [7] . It was followed by a nationwide media campaign initiated in 2002 [8] , while the PCV7 became available and its cost endorsed by the national health insurance early 2003. Pneumococcal carriage and antibiotic resistance trends in DCCs were monitored in AM on an ongoing basis, from 1999 to 2008, allowing assessment of the combined impact of both these events on carriage in this particular setting [9] . We report trends in carriage, serotype distribution and antibiotic susceptibility of SP over the tenyear period from 1999 to 2008.
Methods
Cross-sectional surveys were conducted on a random sample of children attending group day-care from January to March 1999 March , 2002 March , 2004 March , 2006 March and 2008 . Updated lists of all of the DCCs were obtained from the local public health authorities for each survey. Care-centre managers and attending physicians were informed of the survey and their eventual participation was requested in the event that they were randomly selected. For each survey, a two-stage cluster sample was obtained via a random sample of DCCs, among which a random sample of 22 children was drawn, allowing for potential refusal by parents or absentees on the day of the survey. Only those children spending at least three days a week in the centre were included in the sampling frame. Refusal of a DCC centre to participate led to an offer of participation to the next centre on the list, in order to include 25 centres for each survey. In case parents agreed, they were asked to sign an informed consent document and to provide the child's health booklet, which is usually completed by the child's attending physician at each medical visit, and to complete a questionnaire concerning the child's recent medical history and antibiotic treatments over the previous three months. Only those treatments where parents could provide the name of the antibiotic were recorded. On the day of the survey, the investigating physician recorded the immunisation status for the PCV7 from the children's health booklets and, in some instances, when the booklet was not available, immunisation status was provided by the DCC records. Nasopharyngeal aspirates were obtained using a Vygon® 522.06 cannula adapted on a 1-mL syringe. The cannula was then transferred in a transport medium (Portagerm®, bioMér-ieux, Lyon, France) to the Laboratoire d'Antibiologie of Nice University Hospital.
The study protocol was approved by the Nice University Hospital Ethics Committee.
Microbiology
Samples were submitted to direct microscopic examination and cultured on blood agar. Pneumococcal isolates were identified by Gram stain and susceptibility to optochin. The susceptibility of pneumococcal isolates to antibiotics was determined by disc diffusion to oxacillin (1 μg and 5 μg), erythromycin, clindamycin, chloramphenicol and tetracycline. Susceptibility to trimethoprim/sulfamethoxazole combination was tested on separate lysed blood agar plates.
Penicillin, amoxicillin and ceftriaxone minimal inhibitory concentrations (MICs) were determined for strains with a 1 μg oxacillin diameter below 19 mm and/or oxacillin 5 μg below 26 mm by E-test® (BMD, France) and strains were classified as penicillin-intermediate (MIC>0.064 g/ml) or penicillin-resistant (MIC>1 μg/ml) according to the recommendations put forward by the Antibiogram Committee of the French Microbiological Society (Comité de l'Antibiogramme de la Société Française de Microbiologie; http://nosobase.chulyon.fr/recommandations/sfm/2010_antibiotiques_casfm.pdf). Breakpoints for amoxicillin and ceftriaxone were >0.5 μg/ml and >2 μg/ml, respectively. Serotypes were analysed using the Quellung reaction, with antisera provided by the Statens Serum Institute (Copenhagen, Denmark). These antisera concerned the following serotypes: 6A, 6B, 9V, 14, 19A, 19F, 23F and 24. In 2004, strains not reacting with any of those antisera were sent to the National Pneumococcal Reference Center in Paris for identification. From 2006, all serotype determinations, including formerly unidentified serotypes of stored isolates from the previous surveys, were conducted in the Laboratoire d'Antibiologie of Nice University Hospital with pneumococcal latex pool antisera and factor antisera from the Statens Serum Institute to identify specific serotypes included in the PCV7 formulation.
Regional epidemiology
Antibiotic prescription rates were confronted with regional sentinel surveillance data provided by the regional influenza surveillance sentinel physicians (Groupe Régionaux d'Observation de la Grippe). This surveillance is conducted every year from October 1st (week 40) to April 15th (Week 15), as participating physicians report every week the number of patients with influenza-like respiratory tract infection among children aged 0 to 4 years. The available aggregated regional data for the Provence Alpes Côte d'Azur (PACA) region include the Alpes Maritimes area.
Sample size
In order to estimate the proportion of SP carriers within 5% and with 95% confidence, with a hypothesis of 25% carriers of non-susceptible isolates, the required sample size for each survey was calculated to be 288.
Statistical analysis
Data were analysed using Epi-Info 6c and SPSS © software. Univariate analysis was performed using the Chi-square test with a 5% degree of significance. Means were compared using analysis of variance (ANOVA) or the non-parametric Kruskal-Wallis test for unequal variances.
Results

Population characteristics
The AM in south-eastern France has a population of approximately one million, and a birth rate of 11 per 1,000 inhabitants. In France, DCCs cater for children aged 3 months to 3 years of age. There were 58 DCCs in 1999, with a total capacity of 2,800 children. This increased gradually over the years to reach 97 DCCs, with an overall capacity of approximately 5,000 attendees in 2008. Over the five surveys, nasopharyngeal samples were obtained from a total of 1,604 children distributed among the 25 DCCs, aged 3 to 39 months. The number of participating children and their characteristics for each survey are described in Table 1 . No major variation in distribution by age and gender was observed over the study period.
Antibiotic prescriptions
The proportion of children who received an antibiotic prescription within the three months prior to enrolment, as reported by parents, decreased by 50% between 1999 The serotype distribution for each survey is shown in Fig. 1 (Fig. 2) .
Antibiotic susceptibility
Overall, susceptibility to all of the tested antibiotics increased significantly over the study period, up to the 2006 survey (p<10 −3 for each tested antibiotic) and then stabilised (Fig. 3) Penicillin MICs of most PDSP isolates remained at the intermediate level and no significant change was observed regarding the MIC distribution. None were resistant to either amoxicillin or ceftriaxone over the study period, although 41% and 50% were not fully susceptible to these respective compounds in 2008 (Fig. 4) , and, that year, serotype 19A accounted for 57% of amoxicillin nonsusceptible and 55% of ceftriaxone non-susceptible isolates (Fig. 5 ).
Regional epidemiology
Data from the respiratory tract infection community-based sentinel surveillance group for the PACA region show a peak incidence rate in the 2001-2002 winter season for the 0-4-year-old age group (Fig. 5) Vaccine serotypes Non-vaccine serotypes .78, respectively). However, the difference was not significant.
Discussion
Our five consecutive surveys describe a ten-year trend in pneumococcal carriage among healthy children who attended a DCC at least 3 days a week in south-eastern France, covering a period which saw the introduction and wide use of pneumococcal conjugate vaccine, and the implementation of campaigns to reduce antibiotic prescriptions. Such a survey provides an insight into the epidemiology of S. pneumoniae within the community, the day-care setting being notorious for the high carriage rates among its young attendees [3, 4] . As major contributors to SP prevalence in the community, DCC attendees may be considered as sentinels providing an advanced warning system for trends in pneumococcal infection, through regular carriage monitoring in this setting. Huang et al. developed a model exploring both individualand community-level effects of DCC attendance and suggested that the mere presence of DCCs within a community led to a six-fold increase in the odds of carriage for non-attendees [4] .
Although the decline in pneumococcal carriage was moderate, our results show a significant overall drop in the carriage rates of PDSP over the ten-year period concerned, along with fewer antibiotic prescriptions. Considering the high prevalence rates of PDSP initially recorded among this population in the late 1990s, these results are reassuring and confirm those observed both in France and abroad [10, 11] . In central Greece, wide coverage with the PCV7 vaccination was followed by a significant reduction of carriage of highly penicillin-resistant pneumococci among DCC attendees [11] . In France, widespread pneumococcal immunisation combined with a local, followed by a nationwide, campaign to curb antibiotic prescriptions appears to have demonstrated its effects [12] . In a study focusing on children with acute otitis media in France between 2001 and 2006, Cohen et al. observed decreasing carriage rates from 71% to 62% and antibiotic prescriptions from 51% to 38%, with a concomitant rise in penicillin susceptibility, from 23% to 35% of isolates, as immunisation rates reached 91% [2] . In our study, antibiotic use dropped by over a third between 1999 and 2008. The respective impact of each of these two measures, i.e. pneumococcal immunisation and public health campaigns, is difficult to assess in the absence of resistance data concerning other current pathogens over the study period. However, national French observatories for resistance trends among various organisms report decreasing proportions of methicillin-resistant Staphylococ- , according to several surveillance schemes, from 33% to 26%, in favour of an impact of interventions to reduce antibiotic prescriptions [13] . Likewise, serotype distribution has followed trends observed elsewhere. In Portugal, Sá-Leão et al. observed a decrease of vaccine types from 53% in 2001 to 11% in 2006 among children attending DCCs, with 57% vaccinees that year [3] . Huang et al. observed in 2007 that the prevalence of vaccine type was reduced to 3% of isolates among SP carriers in a study concerning children aged 3 to 84 months attending primary care centres in Massachusetts [14] . In our study, vaccine types accounted for only 4% of carriage strains in 2008, with over 90% of children immunised with the PCV7. However, although, as elsewhere, we found high prevalence rates of 19A strains, among which 96% were non-susceptible to penicillin in 2008, the predominant strain that year was serotype 15, of which 34% displayed non-susceptibility to penicillin. Due to the two-year delay between other carriage studies in France and Portugal and our own, it may be that serotype 15 is emerging as a major colonising serotype.
Our positive results should, thus, be considered with caution, as trends in both antibiotic prescription and the carriage of non-susceptible pneumococci appear to have presently stabilised. Regarding antibiotic use, regional sentinel surveillance data do not suggest an increase in the incidence rate of respiratory tract infections in 2008, which would account for the lack of further progress in reducing prescriptions. Whether the present prescription rate among children attending DCCs should be considered as the best we can achieve in France remains to be determined. It may be that sustained efforts are necessary to restrain antibiotic use, and the public health campaign that was implemented in France during [2003] [2004] has not been sufficiently reinforced, nor specifically targeted towards DCC directors, whose exclusion policies have been shown, in a study conducted in Minnesota, to exert a major influence on antimicrobial prescription [15] .
Pneumococcal carriage rates remain high, and, as observed by others, the increasing prevalence of penicillin non-susceptible serotypes 19A and 6A (included in the newly available PCV13) and that of other non-vaccine serotypes exhibiting antibiotic resistance, namely, serotype 15 (not included in the PCV13), are a cause for concern [16] . Vaccine escape by genetic recombination at the capsular locus has been documented, with concomitant change of serotype and penicillin susceptibility [17] .
The surveillance of invasive pneumococcal disease reflects similar changes. In France, coverage by the PCV7 of invasive pneumococcal isolates in children below 2 years of age dropped to below 10% in 2008, while the newly licensed PCV13 covered 68% of those strains [18] . In a multi-centre retrospective cohort study conducted in northern France, the incidence rate of invasive pneumococcal disease observed among children below 2 years of age between 2005 and 2008 increased 6.5-fold, from 1.8/100,000 to 11.9/100,000, and was caused by non-vaccine serotypes [19] .
Regarding antimicrobial treatment, although fewer antimicrobials have been prescribed, those most frequently used may yet interfere with attempts to curb resistance. Indeed, French guidelines recommend treating acute otitis media in children below 2 years of age with an amoxicillinclavulanate combination or third-generation cephalosporins; declining prescriptions for other respiratory tract infections (i.e. common colds) may influence the distribution of prescribed antibiotics in favour of these compounds. Ease of administration (twice-daily) makes third-generation cephalosporins more attractive to parents and day-care personnel and have, thus, been increasingly favoured; however, they are known to select for resistant strains [20, 21] . 
Conclusion
We have attempted to counter antibiotic-driven selective pressure with vaccine-driven selection, which has proved to be highly effective in reducing the incidence of invasive disease, and also in modifying the nasopharyngeal pneumococcal niche by introducing new colonising strains. At the same time, fewer antibiotic prescriptions have eased the burden of resistant organisms. However, previously infrequent replacement strains are now, in turn, developing antimicrobial resistance, demonstrating how easy it is to revert to the initial situation. A new, wider spectrum 13-valent pneumococcal conjugate vaccine (PCV13) is now available in France, exerting yet more selective pressure. It is to be hoped that the benefits reaped in terms of reducing the burden of pneumococcal disease will not be outweighed by the potential virulence of replacement strains or the persistence of inappropriate antibiotic use.
